Half-dose bevacizumab appears safe for preventing bleeding prior to vitrectomy

Investigators evaluated the optimal dose of preoperative intravitreal bevacizumab in patients undergoing vitrectomy for proliferative diabetic retinopathy (PDR).
Source: AAO

Posted in: Uncategorized

Leave a response

658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553